000			nab a22 7a 4500
999			_c15916 _d15916
003			PC15916
005			20210218130725.0
008			200507b xxu||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_91545 _aOrtiz de Frutos, Francisco Javier _eDermatología Médico-Quirúrgica y Venereología
245	0	0	_aAssessment of severity and quality of life in chronic urticaria. _h[artículo]
260			_bJournal of investigational allergology & clinical immunology, _c2014
300			_a24(2):80-6.
500			_aFormato Vancouver: Jáuregui I, Ortiz de Frutos FJ, Ferrer M, Giménez-Arnau A, Sastre J, Bartra J et al. Assessment of severity and quality of life in chronic urticaria. J Investig Allergol Clin Immunol. 2014;24(2):80-6.
501			_aPMID: 24834770
504			_aContiene 46 referencias
520			_aChronic urticaria (CU) is very prevalent in the general population and, despite its low mortality, can have devastating effects on the quality of life (QoL) of those who experience it.Therefore, consensus documents on its classification, diagnosis, and treatment have become a necessity. The intensity of urticaria is currently evaluated using indices such as the Urticaria Activity Score and visual analog scales to assess itch or the degree of itch associated with the use of antihistamines. QoL is evaluated using various generic questionnaires and specific tools for skin disease and for CU. In recent years, attempts have been made to combine these evaluations to create a specific tool that would enable us to simultaneously evaluate the severity of the condition and the impact of symptoms on QoL. One such tool is the Urticaria Severity Score, which also allows us to compare global changes brought about by different treatments.
710			_9145 _aServicio de Dermatología Médico-Quirúrgica y Venereología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc15916.pdf _ySolicitar documento
942			_2ddc _cART _n0